ABSTRACT: Although smoking cessation continues to get most of the attention from both researchers and practitioners, treatment for smokeless tobacco (SLT) dependence gets little consideration. The reasons are varied, but essentially smoking is more prevalent, has greater public health implications, and has been the subject of clean air laws and environmental issues that have focused the attention on a burned tobacco, thereby leaving SLT with scant public health attention. This is unfortunate, because the sales of SLT products, especially moist snuff, have increased consistently over the past decade; regular use of these products can result in oral cancer, other negative effects on oral health, and nicotine dependence or addiction. This article will review some unique issues of SLT use that affect cessation and the empirical research on interventions. 
T
here are, of course, many differences between the use of oral tobacco and burned tobacco products. The combustion of tobacco results in special risks to the user and persons in the environment because burning tobacco has unique carcinogenic properties. However, SLT also contains carcinogenic chemicals, known as tobacco-specific carcinogens, such as tobacco-specific nitrosamines (TSNs), which have been directly implicated in causing cancer in laboratory animals. 1 The 1986 Surgeon General's report on SLT and more recent epidemiological research have concluded that the regular use of SLT products can result in cancer in humans as well. 1, 2 In addition to differences in the products themselves, other significant differences between smoking and dipping or chewing have implications for treatment. First, oral tobacco can be used somewhat surreptitiously or secretively, allowing the user to keep the tobacco in his or her mouth constantly, even while working or engaging in physical activity. This also allows the use of SLT in public settings without others knowing (especially if the user learns to swallow the juice). The use of SLT can occur throughout the day, and in some cases, users report going to sleep with a chew or dip in their mouth.
The uptake of nicotine from oral tobacco products also differs from smoked tobacco. Uptake is dependent upon the absorption of the nicotine from the dip or chew into the oral mucosa; therefore, the pH of the product and the mouth affect the absorption rate. In all cases, this absorption is slower than for tobacco smoke taken into the lungs. This slower uptake of nicotine for SLT and the use of the product throughout the day have been seen as making the product less addictive because there is less immediate and frequent reinforcement of nicotine. 3 Ironically, it has been our clinical experience that SLT users seeking treatment often report that they have previously quit smoking and found that to be easier than attempting to quit SLT.
Although the exposure to nicotine can be very high with products containing high levels of bioavailable nicotine, which results in high levels of plasma nicotine, there is little evidence that SLT is more addictive than smoking. However, it is difficult to separate the biological addiction to nicotine and the psychological dependence experienced by the user. One way to estimate the level of addiction or dependence would be to compare the successful quit rates for similarly dependent smokers and chewers, but we currently lack comparable data from cessation studies for each product. In general, SLT cessation studies have reported high rates of cessation; in some comparisons, such as the dental studies cited below, there have been higher quit rates among SLT users than among smokers. In comparable studies assessing the effect of pharmacological adjuncts and nicotine replacement products, there was a higher observed quit rate for SLT users than for smokers at follow up, which also supports this contention. 4 However, that may be a result of many factors. For example, many smokers have been inundated with requests and support for quitting, and those who continue may be more addicted users, whereas SLT users typically have not often been offered cessation services and may therefore be more responsive when they are given treatment.
Unique Issues for SLT Treatment
There are unique issues associated with SLT cessation treatment. First, unlike smokers, most users of moist snuff or chewing tobacco are male, which offers both challenges and opportunities. Male users are less likely to seek treatment, but they are more likely to respond to self-help programs for quitting than are female users. The opportunity to use spouse or partner support for the male quitter is greater because the female partner can be mobilized to help the male partner in quitting. Additionally, there is a high co-use of cigarettes among SLT users, which presents a challenge because the co-use of tobacco products can make it more difficult to quit. Studies of SLT cessation have reported lower success rates for subjects who concurrently smoke cigarettes than for users who only use chew or snuff. 3, 5 There can also be high seasonal or situational variability in use of SLT. For example, professional baseball players use snuff heavily during the season but many reduce their use, and in some cases quit, during the off-season. 6 There may also be higher use of SLT on the job or during some activities such as golfing, fishing, or hunting, with lower use in other social situations. There is a high association of SLT use with some sports and occupations. It has been reported that very high levels of use exist among baseball players and among men in occupations in such areas as firefighting, police work, and the wood products industry. 7 It is ironic that the clean air laws, which were passed to protect workers from environmental smoke, may inadvertently promote the use of SLT products, which can be used as a substitute source of nicotine while working.
There also have been frequent reports of using oral substitutes when quitting. Because the use of oral tobacco involves having something in the mouth, it makes sense that users who are quitting report wanting some form of oral substitute when craving nicotine. This has spawned an industry to satisfy this need. A number of commercial oral substitute products, now marketed in round tins resembling snuff tins, contain a variety of flavored herbal blends with names like "mint snuff" to promote their use as substitutes for moist tobacco snuff. These products and others such as gum, candy, cinnamon sticks, beef jerky, and toothpicks function as important oral substitutes to many users in their quitting, but some users report that these products are counterproductive or unsatisfactory.
Another unique aspect of SLT use that is related to cessation is the high prevalence of oral lesions found in regular daily users of snuff. One study found that 73% of daily SLT users coming to a dental clinic for routine care had identifiable oral lesions. 8 Drawing attention to these soft-tissue oral lesions can be used to motivate the user to quit. In addition, they can be used as a marker for quitting, as most of these lesions will heal quickly if the user does not use SLT for 2 weeks. This "2-week rule" can be a guide in determining if the person should obtain a biopsy of the oral lesion. Finally, lesion healing can provide the user with clear evidence of the benefit of quitting.
Another difference between SLT cessation and smoking cessation is the comparative lack of effect for nicotine replacement therapy (NRT) for SLT users. The use of nicotine patches and nicotine gum have been shown in randomized clinical trials to significantly improve the quit rates of smokers. 9 These aids have therefore been recommended in the Clinical Practice AHRQ guidelines in Treating Tobacco Use and Dependence. 10 Whereas the effects of NRT have been generally reported in clinical trials as doubling the cessation rate for smokers, the effect of these pharmacological adjuncts for SLT cessation has been modest. However, NRT can still be effective in reducing cravings of SLT users. 11 Thus, NRT can be a useful adjunct for behavioral treatments but the effect on cessation rates has been surprisingly small compared with that of smokers.
Review of Published Treatment Studies
Behavioral treatments for SLT dependence have been shown to be effective, but the literature has been modest compared with the voluminous research literature on smoking cessation, with an estimated 6,000 studies being published between 1975 and 1999. 9 Among the studies on SLT reviewed for this article, only 20 met the criteria for offering adequate methodological rigor; of those 20, only 14 were randomized clinical trials (RCT). The studies reviewed here have been divided into (1) behavioral studies and (2) pharmacological studies evaluating the use of nicotine replacement (gum and patches) or bupropion (Zyban). Although a recent review also provided a comparison of SLT treatment studies, 12 the current review will focus on public health interventions, because they seem to be the most costeffective and distributable models for treatment. Table 1 identifies the 8 published RCT studies of SLT cessation using behavioral interventions. The studies have been divided into 4 groups, classified by channel of intervention. The 2 dental studies involved having a dentist or dental hygienist provide a brief intervention to the tobacco-using patient in the context of oral health care. The sports intervention study provided college athletes with oral exams and interventions to help them quit by randomizing colleges to either the intervention or usual care. The group support studies provided volunteer adult subjects with several sessions of behavioral support over a 10-to 12-week period. This multiple-session treatment model required the subjects to visit a clinic, typically for 8 to 10 sessions, where they received group treatment following a protocol comparable with multisession, cognitive behavioral interventions for smoking cessation. The final category of treatment was the self-help model of intervention, in which subjects were provided with a manual or video and some brief counseling via phone calls but were not required to see a therapist or attend office visits. Table 1 provides the quit rates for both treatment and control subjects for each study in each of the 4 categories of treatment at each follow-up period. Data is presented using an intent-to-treat model in which subjects lost to follow-up are considered SLT users. In the case of the dental studies, the quit rates were reported as a continuous quit rate, which is a conservative measure requiring that the subject report abstinence at each follow up assessment. This criterion has also been referred to as consecutive point prevalence. The results of this summary show that the interventions were generally successful, with the treatment condition always having a higher quit rate than for subjects in the control condition. The odds ratios (OR) are modest; however, the standard rule suggests that any OR in which the 95% confidence interval (CI) includes an OR of 1.0 or lower cannot be considered significant. Among the cessation outcome studies, only 3 meet this criterion. The Glover study 13 is problematic, however, because of the very small number of subjects (n ϭ 23) and the brief follow-up (1 to 2 months).Therefore, the results of the Glover study should be viewed with caution. Table 2 shows the overall OR for SLT treatment by category of intervention and length of follow-up. The dental interventions and the sports intervention studies were the best in terms of overall OR when the 95% CI did not include 1.0 or lower. Table 3 summarizes the results of 6 RCTs that evaluated the use of pharmacological adjuncts in SLT cessation interventions. The table shows 2 studies each that evaluated the use of nicotine gum, nicotine patch, and bupropion for aiding in cessation. Note that in each of the trials, the subjects also received behavioral interventions and had to attend multiple sessions with a therapist in group settings. The average number of sessions for these treatments was 8 (range 4 -12) . The studies evaluating the efficacy of using bupropion as an adjunct to behavioral treatment were 2 small pilot studies that showed promising results, with an average OR of 2.1 (95% CI, 1.0 -4.2). Nicotine patches and nicotine gum were less efficacious, with modest ORs ranging from 1.0 to 1.4. The authors of these studies concluded that the use of nicotine replacement did not significantly improve cessation rates of participants. Note that these studies used a double-blind procedure in which both the subject and therapist were blind as to whether the subject was receiving active or placebo medication. At this time, we must conclude that nicotine replacement in the form of gum or patch has not been shown to be efficacious in treating SLT dependence. However, Hatsukami et al 11 concluded that persons receiving active medication reported fewer withdrawal symptoms during cessation and thus could still be an important element in cessation treatment. The authors of articles evaluating the use of NRT for SLT users suggest 
Years of Research on Smokeless Tobacco Cessation
that the nicotine replacement may have been inadequate in light of the subjects' heavy use of SLT. The studies using nicotine gum used only the 2-mg gum because 4-mg gum was not available at the time of the study. Therefore, subjects may not have used enough pieces of gum daily for adequate replacement of their nicotine uptake. In the case of the nicotine patches, there may also have been inadequate replacement of nicotine for subjects. In sum, the beneficial results of active medication for longterm cessation of SLT were much less than reported for smokers.
In reviewing the results of the RCTs in this area, we can conclude that there is strong support for public health interventions and less support for clinical interventions. In the public health model, interventions are provided in the natural context, and the subjects are not required to attend special sessions or multiple treatment sessions run by a specialist trained in behavioral treatment. The dental studies, in which the patient did not sign up for treatment but received the treatment from the dentist or dental hygienist as part of an annual preventive office visit, provide examples of the public health model. The sports intervention studies were done as part of the medical examination of student athletes at the start of the season. The athletes also received an oral examination and feedback, as well as a presentation from the coach and peers trained in the intervention. Here again, the athletes did not sign up for treatment but received the intervention simply as part of the institution's decision to provide the intervention to all athletes on the team. Self-help interventions can also be classified as public health interventions in that a person can request materials or phone calls and not be required to attend treatment in a formal sense. Currently phone counseling is offered by 33 states as part of their telephone help lines and can offer proactive phone counseling based on referral from a health care provider or reactive calls based on users calling the toll-free line and asking for help.
The impact of the public health interventions can be calculated by assessing both the reach of the interventions and the effectiveness of the intervention 14 The reach is defined as the percentage of the targeted group, in this case SLT users, who receive the treatment. The effectiveness can be defined as the long-term abstinence rates associated with the treatment. By multiplying the reach times the effectiveness, we can get an estimate of the impact of the intervention. In the case of the dental interventions, we can estimate that if the intervention were to be widely adopted by dental offices, it could reach an estimated 50% of tobacco users who come to a dental office in any year. Even when estimating a modest sustained quit rate of 7% (based on the difference between quit rates reported for the intervention and control conditions 15 ), the impact could be very significant in terms of public health.
Although clinical interventions may have significantly higher quit rates (even as high as 25 to 40%), they generally reach only a small proportion of SLT users. It has been estimated that only about 5% of smokers ever receive formal assistance in their quitting effort. 16 Therefore, the public health impact of clinical programs is limited by the lack of reach. It is surprising and somewhat disappointing to not see greater cessation rates for clinical interventions because the subject seeks treatment or agrees to treatment, agrees to a consent procedure, and attends several sessions of treatment. The quit rates may be affected by a lack of adherence to the protocol, attrition and drop out from the study, and a selection bias in which subjects agreeing to be in the study may be more dependent on SLT. In the case of pharmacological treatment, the subjects received adjunctive prescriptive medication in addition to the behavioral group treatment. One variable that seems to be shared across the public health interventions shown to be effective was the use of the oral examination to provide feedback on the oral health effects of SLT use. 7 Subjects report that this feedback is a powerful motivator and element in their quitting. Therefore, it is highly recommended that interventions incorporate oral examination feedback, oral substitutes, and pharmacological adjuncts into an intervention for SLT cessation. Group or individual treatment is effective in helping SLT users quit and should be an option for users motivated to quit. However, the use of self-help quitting may be more cost effective even if the quit rates are modest. In the study by , the subjects using the self-help quitting manual alone had a lower overall quit rate than subjects receiving the manual plus a videotape and 2 telephone calls from trained counselors. Analyses indicated the cost of each quit was significantly lower for those receiving only the manual than for those in the assisted self-help condition, and was more effective than the spontaneous quit rates for tobacco users (estimated to be 2.3% based on data from smokers but unknown for SLT users at this time). The estimated incremental cost per quit for a subject using the cessation manual was $234. This is based on using the actual cost of $17.29 to provide the self-help cessation manual to a subject and an incremental effectiveness for this intervention (the improvement over quitting on one's own) of 7.4%.
Recent developments point to the efficacy of using phone counselors as a low-cost way to provide treatment for SLT users and to persons in all areas of the country. In the case of SLT cessation, the prevalence of snuff and chew use is higher in rural areas, where users may have limited access to medical or psychological treatment for dependence. 17, 18 Recent evidence suggests that the phone-counseling model is an effective intervention for smokers; telephone help lines are now developing special protocols for SLT users. Severson et al 19 found significantly better quit rates for subjects receiving the additional support by phone. A careful analysis of the results led the authors of that study to conclude that phone counselors were successful in getting the SLT users to follow more of the recommended steps in the quitting process and to use the materials more effectively. The authors of that study also assessed the supportive behaviors of the spouse or partner and reported that if the partner provided support that was defined as positive (eg, help you think of substitutes for chew or snuff) as opposed to negative (nags or criticizes me for chewing) (examples adapted for SLT from Lichtenstein et al 20 ) , the user was more successful in quitting and staying quit. 21 This is an area that needs more research and may provide an avenue for future interventions in which the spouse or partner is provided with more information on how to be most helpful to their partner's quit effort.
In sum, a developing literature demonstrates that effective interventions are available for users wanting to quit their use of snuff or chewing tobacco. The best evidence to date is supportive of public health interventions that provide treatment in the context of either dental office visits or for sports teams or that provide low-cost self-help assistance to users via phone or mailed materials.
Additionally, a number of recently developed innovative interventions are being evaluated. One involves the use of the Internet to deliver the intervention (ChewFree.com) and another provided a computer-based interactive game-like cessation intervention to adult users. 22, 23 Another innovation is the use of interactive computer-based instruction to train dental health care providers in offering a minimal intervention to their patients. 24 This technology could promote the diffusion to dissemination of a low intensity intervention through dentists and dental hygienists. Additionally, National Institutes of Health-supported studies are underway that will evaluate the use of bupropion for cessation and the use of NRT with adolescent SLT users. Finally, a Department of Defense study has been undertaken that will evaluate the use of proactive phone counseling using a motivational interviewing model for assisting military personnel in quitting.
